Allogene Therapeutics
Allogene Therapeutics is an investor based in Canada, investing in Healthcare & Life Sciences, Medical Device and R D, 1 tracked investment.
About Allogene Therapeutics
Allogene Therapeutics is an investor based in Canada. Brouky tracks 1 investment associated with the firm.
Allogene Therapeutics invests across Healthcare & Life Sciences, Medical Device, R D and Biotech. Coverage extends to 6 sectors in total. Investments are concentrated at Series A.
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. They are focused on delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients.
Investment Focus
Explore Allogene Therapeutics's full profile on Brouky
Portfolio companies, co-investors, AI match scores, and deal flow signals.
Other Investors in Canada
Alex Cruz
Industry & Hardware, artificial intelligence, digital assistants
Ag-West Bio
Consumer, Lifestyle & Services, foodtech, sustainability
Agnico Eagle Mines Limited
Industry & Hardware, Critical Minerals, Mining Tech
AGF
Software & Developer Tools, adtech, advertising
AltaML
Alternative Capital Group
Software & Developer Tools, Cloud Infrastructure, Telecommunications
Alternative Renewable Technologies Fund II
Energy, Environment & Mobility, AgriTech, Sustainability
Altman Capital
Software & Developer Tools, Consumer, Lifestyle & Services, bot detection